Author:
Wiese Jennifer,Derian Nayiri A,Ghimire Shristee,Bambhroliya Zarna,Joshi Tejas
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Epidemiology, predisposing factors, and outcomes of drug-induced liver injury;Björnsson ES;Clin Liver Dis,2020
2. Using the guidance on your mobile device. (2022). Accessed. May 30, 2024: https://www.hcvguidelines.org/.
3. Maviret (glecaprevir/pibrentasvir) 100 mg/40 mg film-coated tablets. summary of product characteristics. (2017). Accessed: May 30, 2024: http://www.mavyret.com/?cid=ppc_ppd_msft_HCV_Branded_hepatitis_c_drug_medicine_glecaprevir_Phrase_USMAVY220222&gclid=....
4. Drug-induced liver injury by glecaprevir/pibrentasvir treatment for chronic hepatitis C infection: a systematic review and meta-analysis;Hung HY;Ann Med,2022
5. A case report of glecaprevir/pibrentasvir-induced severe hyperbilirubinemia in a patient with compensated liver cirrhosis;Yoon JH;Medicine (Baltimore),2019